Scientists found that NOB not only increased the accumulation of chemotherapy drugs in ABCB1-overexpressed cancer cells by inhibiting p-gp but also inhibited the Nrf2/Akt/ERK pathway, thereby enhancing the anticancer effect of paclitaxel in drug-resistant cancer cells [108]. Here, NFE2L2 is linked to cancer.